Left Atrial Appendage (LAA) Occluders

LAA occluder, Watchman

The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably Dec. 11 in a 13-1 vote that the benefits of the Watchman ...

Lariat Procedure Reduces Stroke Risk in Patients Who Cannot Tolerate Blood Thinn

Shore University Medical Center is one of only a handful of hospitals in the country offering the recent U.S. Food and Drug Administration (FDA)-approved Lariat Suture Delivery Device procedure. Electrophysiologists and interventional cardiologist...

AtriCure AtriClip Flex Atrial Fibrillation Therapies Cardiac Surgery LAA Occlude
AtriCure Inc. announced the introduction of the AtriClip Flex, a new device with a more flexible aluminum shaft that allows surgeons to better maneuver within...
July 22, 2014 — AtriCure announced it has sold more than 34,000 AtriClip left atrial appendage (LAA) exclusion system devices worldwide.
atrial fibrillation, LARIAT
Doctors at the Stony Brook Heart Institute Electrophysiology Lab are using a new nonsurgical technique called the Lariat Suture Delivery Device to treat...
Watchman, LAA occluder, atrial fibrillation
The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably Dec. 11 in a 13-1 vote...
AtriCure AtriClip Flex Atrial Fibrillation Therapies Cardiac Surgery LAA Occlude
AtriClip Flex is a new device from AtriCure with a more flexible aluminum shaft that allows surgeons to better maneuver within a patient’s
Philips Healthcare received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its precision planning application...
The Solo Smart Aortic Pericardial Heart Valve from Sorin Group is the first valve with a removable stent to be approved in the U.S. market...

Articles

atrial fibrillation, LARIAT
Doctors at the Stony Brook Heart Institute Electrophysiology Lab are using a new nonsurgical technique called the Lariat Suture Delivery Device to treat...
Watchman, LAA occluder, atrial fibrillation
The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably Dec. 11 in a 13-1 vote...
laa occluders structural heart atrial fibrillation atricure atriclip exclusion
AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and Drug Administration’s (FDA’s) approval to begin enrollment in...
LAA occluder, Watchman
According to Millennium Research Group (MRG), the anticipated Food and Drug Administration (FDA) approval of Boston Scientific's Watchman device will...

Video Center

By Dave Fornell, editor of DAIC Magazine The key take away messages from the 26th annual...
4 days 18 hours ago
As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
3 weeks 6 days ago
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
9 weeks 4 days ago
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
This webinar demonstrates the Centricity Cardio Enterprise Solution (CCE), a solution that can help cardiology departments and hospital administrators to...